DRI Healthcare Trust (TSE:DHT.UN – Get Free Report)’s share price reached a new 52-week high during trading on Thursday . The company traded as high as C$17.31 and last traded at C$17.25, with a volume of 8633 shares changing hands. The stock had previously closed at C$16.67.
DRI Healthcare Trust Trading Up 1.2%
The stock’s 50 day moving average price is C$16.07 and its two-hundred day moving average price is C$15.56. The firm has a market capitalization of C$929.47 million, a price-to-earnings ratio of -17.95 and a beta of 0.35.
About DRI Healthcare Trust
DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.
Featured Stories
- Five stocks we like better than DRI Healthcare Trust
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.
